Sun et al.6 have demonstrated that the greatest number of LCSCs (EPCAM+, CD13+, and CD44+) is found in the stiffer invasive front of the liver cancer tissue in a rat liver cancer model, thus indicating that stiffer liver cancer tissue (marginal part) is more suitable for potentiating the stemness of LCSCs. The gene discussed is CD44; the disease is liver cancer.